Company / SG&A per Share
MADRIGAL PHARMACEUTICALS, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$36.98
FY2025
5-year range
$2.41 / $36.98
FY2021-FY2025
Trend
+69.0%
vs FY2024
Sector context
#4 of 210
Health Care
What the data says
Among 210 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the bottom 2% for sg&a per share. SG&A per Share has increased for 5 consecutive years, from $1.42 in FY2020 to $36.98 in FY2025.
Based on SEC 10-K filings.
36.98 in FY2025 with a 5-year CAGR of +92.0%. Top quartile in the Health Care sector.
Increased from $5.97 to $36.98 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +136.1%
- 5-Year CAGR
- +92.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 210This company $36.98 Sector average $40.75
▼
-9.2% below sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 69.0% year-over-year.
- Ranks #4 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.98 | +69.0% |
| FY2024 | $21.89 | +266.4% |
| FY2023 | $5.97 | +112.7% |
| FY2022 | $2.81 | +16.7% |
| FY2021 | $2.41 | +69.8% |
| FY2020 | $1.42 | -3.7% |
| FY2019 | $1.47 | +42.3% |
| FY2018 | $1.03 | +65.0% |
| FY2017 | $0.63 | -64.9% |
| FY2016 | $1.78 | +866.2% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026